Results 141 to 150 of about 311,191 (157)

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Circulation Research, 2020
Peng Zhang, Lihua Zhu, Jingjing Cai
exaly  

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Circulation, 2005
CARLOS M Ferrario, Mark C Chappell, David B Averill   +2 more
exaly  

Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent

Hypertension, 2020
Jan Wysocki, Minghao Ye, Pan Liu
exaly  

FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1–7) Axis in Mice

Cell Metabolism, 2018
Xuebo Pan, Yihui Shao, Fan Wu
exaly  

Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody

Cell, 2019
Laura M Wingler, Conor Mcmahon, Dean P Stauß   +2 more
exaly  

Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats

Circulation, 2002
Anton J M Roks, René A Tio, Albert J H Suurmeijer   +2 more
exaly  

Key fibrogenic mediators: old players. Renin–angiotensin system

Kidney International Supplements, 2014
Giuseppe Remuzzi, Ariela Benigni
exaly  

Influence of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor Gene Polymorphisms on Aortic Stiffness in Normotensive and Hypertensive Patients

Circulation, 1996
Athanase Benetos, Roland Asmar, Odette Poirier   +2 more
exaly  

The Cardiac Renin-Angiotensin System

Circulation Research, 1999
David E Dostál, Kenneth M Baker
exaly  

Nox1 Is Involved in Angiotensin II–Mediated Hypertension

Circulation, 2005
Kuniharu Matsuno, Hiroyuki Yamada, Kazumi Iwata   +2 more
exaly